• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hydrophilic and lipophilic statin and clinical outcomes in individuals with alcohol-associated liver disease.

作者信息

Danpanichkul Pojsakorn, Kim Donghee, Nah Benjamin, Wijarnpreecha Karn, Liangpunsakul Suthat

机构信息

Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA.

出版信息

Clin Mol Hepatol. 2025 Jul;31(3):e273-e276. doi: 10.3350/cmh.2025.0474. Epub 2025 May 27.

DOI:10.3350/cmh.2025.0474
PMID:40660769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12260642/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edd8/12260642/f3ee7902dfd7/cmh-2025-0474f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edd8/12260642/f3ee7902dfd7/cmh-2025-0474f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edd8/12260642/f3ee7902dfd7/cmh-2025-0474f1.jpg

相似文献

1
Hydrophilic and lipophilic statin and clinical outcomes in individuals with alcohol-associated liver disease.亲水性和亲脂性他汀类药物与酒精性肝病患者的临床结局
Clin Mol Hepatol. 2025 Jul;31(3):e273-e276. doi: 10.3350/cmh.2025.0474. Epub 2025 May 27.
2
Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis.他汀类药物使用对乳腺癌复发和死亡率的影响：一项系统评价和荟萃分析。
Int J Cancer. 2016 Sep 15;139(6):1281-8. doi: 10.1002/ijc.30185. Epub 2016 May 31.
3
Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: A systematic review and meta-analysis of controlled trials.他汀类药物对系统性红斑狼疮患者疾病活动度和 C 反应蛋白浓度的影响：一项对照试验的系统评价和荟萃分析。
Autoimmun Rev. 2016 Apr;15(4):344-53. doi: 10.1016/j.autrev.2015.12.007. Epub 2015 Dec 30.
4
Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.脂溶性他汀类药物与慢性病毒性肝炎患者肝细胞癌和死亡风险：来自瑞典全国人群的结果。
Ann Intern Med. 2019 Sep 3;171(5):318-327. doi: 10.7326/M18-2753. Epub 2019 Aug 20.
5
Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders.针对正在接受物质使用障碍治疗或已康复的人群的戒烟干预措施。
Cochrane Database Syst Rev. 2016 Nov 23;11(11):CD010274. doi: 10.1002/14651858.CD010274.pub2.
6
Statin use and oncological outcomes in a propensity-matched cohort of nonmetastatic castration resistant prostate cancer patients of the ARAMIS trial.在ARAMIS试验中，对非转移性去势抵抗性前列腺癌患者的倾向匹配队列进行他汀类药物使用与肿瘤学结局的研究。
Urol Oncol. 2025 Mar;43(3):193.e7-193.e17. doi: 10.1016/j.urolonc.2024.08.023. Epub 2024 Oct 29.
7
Comparative efficacy of β-blockers on mortality and cardiovascular outcomes in patients with hypertension: a systematic review and network meta-analysis.β受体阻滞剂对高血压患者死亡率和心血管结局的比较疗效：一项系统评价和网状Meta分析
J Am Soc Hypertens. 2017 Jul;11(7):394-401. doi: 10.1016/j.jash.2017.05.001. Epub 2017 May 18.
8
Parental liver disease mortality is associated with unfavorable outcomes in patients with alcohol-associated hepatitis.父母肝脏疾病死亡率与酒精性肝炎患者的不良预后相关。
Hepatol Commun. 2025 May 23;9(6). doi: 10.1097/HC9.0000000000000666. eCollection 2025 Jun 1.
9
Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.他汀类药物的使用与慢性肝病患者肝硬化及相关并发症风险的关系：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1521-1530.e8. doi: 10.1016/j.cgh.2017.04.039. Epub 2017 May 4.
10
Pharmacotherapy for anxiety and comorbid alcohol use disorders.焦虑症合并酒精使用障碍的药物治疗
Cochrane Database Syst Rev. 2015 Jan 20;1(1):CD007505. doi: 10.1002/14651858.CD007505.pub2.

本文引用的文献

1
Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000-2021.2000 - 2021年酒精性肝病、肝癌及酒精使用障碍的全球流行病学
Clin Mol Hepatol. 2025 Apr;31(2):525-547. doi: 10.3350/cmh.2024.0835. Epub 2025 Jan 9.
2
Alcohol-associated liver disease: Natural history, management and novel targeted therapies.酒精性肝病：自然史、管理与新型靶向治疗
Clin Mol Hepatol. 2025 Feb;31(Suppl):S112-S133. doi: 10.3350/cmh.2024.0709. Epub 2024 Oct 31.
3
Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality.
他汀类药物的使用与肝病、肝细胞癌和与肝脏相关的死亡率的关系。
JAMA Netw Open. 2023 Jun 1;6(6):e2320222. doi: 10.1001/jamanetworkopen.2023.20222.
4
A global federated real-world data and analytics platform for research.一个用于研究的全球联合真实世界数据与分析平台。
JAMIA Open. 2023 May 13;6(2):ooad035. doi: 10.1093/jamiaopen/ooad035. eCollection 2023 Jul.
5
Cardiovascular Outcomes in Patients With Biopsy-proven Alcohol-related Liver Disease.酒精性肝病患者的心血管结局。
Clin Gastroenterol Hepatol. 2023 Jul;21(7):1841-1853.e12. doi: 10.1016/j.cgh.2022.10.022. Epub 2022 Nov 1.
6
Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks.未接种疫苗人群中新冠病毒病康复者的长期心血管结局：一项来自TriNetX美国协作网络的回顾性队列研究
EClinicalMedicine. 2022 Nov;53:101619. doi: 10.1016/j.eclinm.2022.101619. Epub 2022 Aug 11.
7
Hydrophilic Versus Lipophilic Statin Treatments in Patients With Renal Impairment After Acute Myocardial Infarction.急性心肌梗死后肾功能损害患者的亲水性他汀与亲脂性他汀治疗。
J Am Heart Assoc. 2022 Jun 7;11(11):e024649. doi: 10.1161/JAHA.121.024649. Epub 2022 Jun 3.
8
Hydrophilic or Lipophilic Statins?亲水性还是亲脂性他汀类药物？
Front Cardiovasc Med. 2021 May 20;8:687585. doi: 10.3389/fcvm.2021.687585. eCollection 2021.
9
Impact of lipophilic vs hydrophilic statins on the clinical outcome and biomarkers of remodelling in heart failure patients: A prospective comparative randomized study.亲脂性与亲水性他汀类药物对心力衰竭患者临床结局和重塑生物标志物的影响：一项前瞻性比较随机研究。
Br J Clin Pharmacol. 2021 Jul;87(7):2855-2866. doi: 10.1111/bcp.14695. Epub 2021 Jan 3.
10
Statin Lipophilicity and the Risk of Incident Heart Failure.他汀类药物的亲脂性与心力衰竭事件风险。
Cardiology. 2020;145(6):375-383. doi: 10.1159/000506003. Epub 2020 Apr 14.